VALSACOMBI
Film-coated tablet, 160mg + 12.5mg
RxActive license
Active substance (INN)
hydrochlorothiazidevalsartan
Pharmaceutical form
Pharmaceutical formFilm-coated tablet
Strength160mg + 12.5mg
PackagingUkupno 28 film tableta u blisteru (2x14) u kartonskoj kutiji
ManufacturerKrka d.d., Slovenia
Therapeutic groupCardiovascular system (C09DA03)
Marketing authorization holderDIO STRANOG DRUŠTVA "KRKA D.D. NOVO MESTO" SLOVENIJA - PREDSTAVNIŠTVO PODGORICA
Authorization dateMarch 12, 2025
Analogs in Montenegro
20Other medicines with the same active substance
AMPRIL HDRx
Tablet, 5mg + 25mgAMPRIL HLRx
Tablet, 2.5mg + 12.5mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgDIOVANRx
Film-coated tablet, 80mgDIOVANRx
Film-coated tablet, 40mgENAP-HRx
Tablet, 10mg + 25mgENTRESTORx
Granules in capsules for opening, 16mg/15mgENTRESTORx
Granules in capsules for opening, 6mg/6mgENTRESTORx
Film-coated tablet, 51mg + 49mgENTRESTORx
Film-coated tablet, 103mg + 97mgENTRESTORx
Film-coated tablet, 26mg + 24mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgIRBENIDA PLUSRx
Film-coated tablet, 150mg/12.5mgIRBENIDA PLUSRx
Film-coated tablet, 300mg/12.5mgIRUZIDRx
Tablet, 10mg + 12.5mgIRUZIDRx
Tablet, 20mg + 12.5mgSource: CInMED register